Your browser is no longer supported. Please, upgrade your browser.
Settings
GKOS Glaukos Corporation daily Stock Chart
GKOS [NYSE]
Glaukos Corporation
Index- P/E359.59 EPS (ttm)0.12 Insider Own1.00% Shs Outstand34.66M Perf Week9.08%
Market Cap1.53B Forward P/E81.76 EPS next Y0.54 Insider Trans-74.38% Shs Float32.79M Perf Month10.49%
Income4.50M PEG- EPS next Q0.05 Inst Own39.00% Short Float9.78% Perf Quarter-12.05%
Sales127.20M P/S12.05 EPS this Y105.80% Inst Trans14.57% Short Ratio5.18 Perf Half Y30.94%
Book/sh3.60 P/B12.29 EPS next Y156.40% ROA3.40% Target Price54.39 Perf Year53.84%
Cash/sh2.86 P/C15.45 EPS next 5Y- ROE4.00% 52W Range26.96 - 52.49 Perf YTD28.95%
Dividend- P/FCF47.46 EPS past 5Y- ROI3.60% 52W High-15.74% Beta-
Dividend %- Quick Ratio7.90 Sales past 5Y- Gross Margin85.70% 52W Low64.06% ATR1.52
Employees264 Current Ratio8.50 Sales Q/Q55.40% Oper. Margin3.20% RSI (14)61.21 Volatility3.41% 3.70%
OptionableYes Debt/Eq0.00 EPS Q/Q-7.40% Profit Margin3.50% Rel Volume2.75 Prev Close43.99
ShortableYes LT Debt/Eq0.00 EarningsMay 03 AMC Payout0.00% Avg Volume619.48K Price44.23
Recom1.50 SMA208.65% SMA505.04% SMA20010.97% Volume1,705,074 Change0.55%
Mar-02-17Reiterated Cantor Fitzgerald Overweight $45 → $54
Jan-06-17Upgrade Stifel Hold → Buy $42 → $45
Oct-27-16Initiated Wells Fargo Outperform
Aug-02-16Reiterated Cantor Fitzgerald Buy $35 → $41
Jun-03-16Initiated Cantor Fitzgerald Buy $35
Apr-08-16Initiated Stifel Hold
Feb-09-16Initiated Piper Jaffray Overweight $19
Jul-20-15Initiated JP Morgan Overweight $38
Jul-20-15Initiated Goldman Neutral $29
Jul-20-15Initiated Cantor Fitzgerald Buy $35
Jul-20-15Initiated BofA/Merrill Buy
Jun-22-17 08:12AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : June 22, 2017 Capital Cube
Jun-21-17 07:00AM  Combining Implantation of Glaukos iStent inject® Trabecular Micro-Bypass with Topical Travoprost Provides Sustained IOP Reduction and Favorable Safety Profile, According to New Study Business Wire
Jun-19-17 03:24PM  ETFs with exposure to Glaukos Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-10-17 02:06PM  3 Growth Stocks for Bold Investors Motley Fool
May-30-17 04:30PM  Glaukos Announces Participation in William Blair Growth Stock Conference Business Wire
May-24-17 12:05PM  Which Stocks Are Showing Rising Relative Strength? Investor's Business Daily
12:03PM  Can This 2015 Medical IPO Inject New Life Into Its Stock? Investor's Business Daily
May-22-17 04:30PM  Study Reveals Potential Cost Efficiency of Using Two Glaukos iStent® Trabecular Micro-Bypass Stents to Treat Elevated IOP in Glaucoma Patients Business Wire
May-06-17 07:50PM  Edited Transcript of GKOS earnings conference call or presentation 3-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-03-17 07:27PM  Glaukos beats Street 1Q forecasts Associated Press
04:15PM  Glaukos Corporation Announces First Quarter 2017 Financial Results Business Wire
07:00AM  Glaukos Completes Patient Enrollment in Phase II Clinical Trial for iDose Travoprost Intraocular Implant in Glaucoma Patients Business Wire
May-02-17 07:00AM  Glaukos Announces Participation in Bank of America Merrill Lynch 2017 Health Care Conference Business Wire
May-01-17 04:59PM  Glaukos Corp. Value Analysis (NYSE:GKOS) : May 1, 2017 Capital Cube
07:00AM  Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery Business Wire
Apr-28-17 08:19AM  Glaukos Corp. breached its 50 day moving average in a Bullish Manner : GKOS-US : April 28, 2017 Capital Cube
06:54AM  Cerner (CERN) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-27-17 09:46AM  CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y Zacks
Apr-26-17 10:32AM  Stryker (SYK) Earnings and Revenues Beat Estimates in Q1 Zacks
Apr-19-17 07:00AM  Glaukos Corporation to Release First Quarter 2017 Financial Results after Market Close on May 3 Business Wire
Apr-14-17 08:24AM  Glaukos Corp. breached its 50 day moving average in a Bearish Manner : GKOS-US : April 14, 2017 Capital Cube
Apr-13-17 05:02PM  Why Apogee Enterprises, Embraer, and Glaukos Slumped Today Motley Fool -7.60%
04:42PM  Glaukos Dives To 1-Month Low On Proposal To Slash Reimbursements Investor's Business Daily
07:00AM  International Study Shows Two Glaukos iStent® Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction Business Wire
Apr-12-17 04:30PM  Glaukos Corporation Acquires IOP Sensor System from DOSE Medical Business Wire
Apr-10-17 10:20AM  3 Stocks That Are Overvalued Motley Fool -7.61%
Apr-09-17 03:26PM  Glaukos shares risk steep decline as rivals pressure - Barron's Reuters
03:11PM  Glaukos shares risk steep decline as rivals pressure - Barron's Reuters
Apr-08-17 12:21AM  [$$] Skeptics Eye Potential Trouble for Glaukos Barrons.com
Apr-05-17 04:49PM  ETFs with exposure to Glaukos Corp. : April 5, 2017 Capital Cube
Mar-21-17 01:04PM  GLAUKOS CORP Financials
Mar-16-17 07:00AM  Glaukos Announces Five-Year Extensions for Three Category III CPT Codes Related to Micro-Invasive Glaucoma Surgery Business Wire
Mar-15-17 04:11PM  GLAUKOS CORP Files SEC form 10-K, Annual Report
Mar-10-17 04:32PM  GLAUKOS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-06-17 01:42PM  ETFs with exposure to Glaukos Corp. : March 6, 2017 Capital Cube
Mar-03-17 11:21AM  Glaukos Corp. :GKOS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Capital Cube -6.27%
07:30AM  Amedisys Stock Up on Solid Earnings, Reimbursement Woes Stay Zacks
Mar-02-17 08:15PM  Stocks, Dow Jones close down: Snap debuts, Caterpillar sinks after search warrants at bizjournals.com
08:15PM  Stocks, Dow Jones close down: Snap debuts, Caterpillar sinks after search warrants American City Business Journals
04:06PM  Glaukos Stock Hits Record High On Q4 Sales Beat, Posts No Losses Investor's Business Daily
01:04PM  Glaukos Corp. Stock Notches Gains With Eye-Popping Results Motley Fool
10:53AM  Glaukos Stock Hits Record High On Q4 Sales Beat, Posts No Losses
07:56AM  VWR Corp Poised on Strong Earnings Amid Currency Headwinds Zacks
01:18AM  Edited Transcript of GKOS earnings conference call or presentation 1-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
Mar-01-17 05:51PM  Glaukos tops Street 4Q forecasts
04:50PM  Broadcom, Glaukos Earnings Beat; Shake Shack Sluggish; Box, Planet Fitness Guide Low
04:15PM  Glaukos Corporation Announces Fourth Quarter & Full Year 2016 Financial Results Business Wire
04:13PM  GLAUKOS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:06AM  Penumbra (PEN) Q4 Loss Narrower than Expected, Sales Top
08:58AM  Inogen (INGN) Tops Earnings & Revenues in Q4; View Upbeat
08:56AM  Mead Johnson Acquires Bega's Strategic Capabilities Business
08:44AM  Varian (VAR): Calypso Tumor Tracking System Now in Brazil
07:58AM  Integer (ITGR) Beats Earnings and Revenue Estimates in Q4
07:38AM  Amedisys (AMED) Earnings Top Q4 Estimates, Revenues Lag
07:07AM  Q4 2016 Glaukos Corp Earnings Release - After Market Close
Feb-28-17 04:30PM  Glaukos Technologies Featured in Eight Presentations at 2017 American Glaucoma Society Meeting Business Wire
03:38PM  Medtronic (MDT) Presents 5-Year Cost Data of CRT Devices
01:30PM  Allscripts Launches Clinical Pathways for Cancer Treatment
08:26AM  MedTech Stocks' Q4 Earnings on Mar 1: ICUI, GKOS & EGRX
Feb-27-17 08:31AM  VWR Corporation (VWR) Tops Earnings in Q4; View Dull
07:00AM  Glaukos Announces Participation in 29th Annual ROTH Conference Business Wire
06:59AM  Integra (IART) Posts In-Line Q4 Earnings, Issues 2017 View
Feb-24-17 05:48PM  Will Mylan, Glaukos, Supernus Live Up To Q4 Growth Views Next Week?
09:24AM  3 Most Wildly Overvalued Stocks in Healthcare at Motley Fool
07:19AM  Medtronic Poised on Strong Fundamentals Despite Several Woes
07:17AM  Omnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise
Feb-23-17 02:02PM  Patterson Companies (PDCO) Earnings Beat Estimates in Q3
10:04AM  Fresenius Medical (FMS) Tops Earnings in Q4, View Upbeat
09:55AM  Inovalon (INOV) Q4 Earnings In Line, Revenue Beat Estimates
09:36AM  Align Expands Internationally with Dental Couture Buyout
09:07AM  Teleflex (TFX) Gains FDA Approval for TrapLiner Catheter
08:52AM  Henry Schein Inks Agreement for Rijuven's CardioSleeve
Feb-22-17 08:26AM  Wright Medical (WMGI) Posts Narrower-than-Expected Q4 Loss
08:18AM  DaVita (DVA) Ties Up with Cigna Arm, Expands in Los Angeles
07:00AM  Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos Corporation as Chief Medical Officer Business Wire
Feb-21-17 12:34PM  Henry Schein (HSIC) Tops Q4 Earnings, Reaffirms '17 View
12:32PM  Ecolab's (ECL) Earnings, Revenues Miss Estimates in Q4
09:52AM  Medtronic (MDT) Beats on Q3 Earnings, Retains Sales View
08:05AM  Henry Schein to Acquire SAS to Strengthen Dental Offerings
Feb-18-17 06:05PM  These N.Y.C. companies are trading at all-time highs as stocks surge in 'Trump rally' at bizjournals.com
04:00PM  These L.A.-area companies are trading at all-time highs as stocks surge in 'Trump rally' at bizjournals.com
Feb-17-17 09:34AM  DENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues
09:30AM  Zacks.com featured highlights: Xcerra, Glaukos, Nova Measuring Instruments, Customers Bancorp and DNB Financial
07:59AM  DaVita (DVA) Earnings Beat Estimates, Revenues Lag in Q4
07:55AM  GNC Holdings (GNC) Misses Q4 Earnings, Revenues Decline Y/Y
07:50AM  Medtronic's Freezor Xtra Catheter Gains FDA Nod for AVNRT
Feb-16-17 10:07AM  LabCorp (LH) Q4 Earnings and Revenues Beat, Offers View
09:59AM  Chemed (CHE) Misses Q4 Earnings, Sales; Offers '17 View
09:04AM  Omnicell (OMCL) Q4 Earnings Deteriorate Y/Y, Revenues Miss
08:53AM  CryoLife (CRY) Earnings Beat Estimates, Revenues Lag in Q4
08:50AM  8 Stocks with Recent Price Strength to Enhance Your Returns
07:00AM  Glaukos Completes Patient Enrollment in Pivotal Phase of U.S. IDE Clinical Trial for iStent SUPRA® Business Wire
Feb-15-17 09:30AM  Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal
08:57AM  Genomic Health (GHDX) Earnings Surpass Estimates in Q4
Feb-14-17 09:30AM  Medtronic (MDT) Adds New Tools, Expands Coronary Suite
09:27AM  Bruker (BRKR) Beats on Q4 Earnings, Issues 2017 Guidance
08:12AM  Omnicell Partners with DCH Health for Sterile Compounding
Feb-13-17 09:41AM  Varian (VAR) Wins Competitive Bid for Six Shanghai Hospitals
09:16AM  STERIS (STE) Cuts 2017 View: Will it See Gloomy Days Ahead?
Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration. It markets its products through direct sales force in the United States and internationally, as well as through distribution partners in Europe, the Asia Pacific, and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SILVERSTEIN JONATHANDirectorMar 14Sale44.5474,1003,300,41416,435Mar 14 07:47 PM
ORBIMED ADVISORS LLCDirectorMar 14Sale44.5474,1003,300,41416,435Mar 14 07:39 PM
SILVERSTEIN JONATHANDirectorMar 13Sale45.30211,4109,577,45417,134Mar 14 07:47 PM
ORBIMED ADVISORS LLCDirectorMar 13Sale45.30211,4109,577,45417,134Mar 14 07:39 PM
SILVERSTEIN JONATHANDirectorMar 10Sale45.9897,0284,461,34719,129Mar 14 07:47 PM
ORBIMED ADVISORS LLCDirectorMar 10Sale45.9897,0284,461,34719,129Mar 14 07:39 PM
SILVERSTEIN JONATHANDirectorMar 03Sale47.0555,7722,624,07320,044Mar 07 06:52 PM
ORBIMED ADVISORS LLCDirectorMar 03Sale47.0555,7722,624,07320,044Mar 07 06:48 PM
Burns Thomas WilliamChief Executive OfficerFeb 02Sale42.5850,0002,129,000210,240Feb 03 04:11 PM
Calcaterra Chris M.Chief Commercial OfficerJan 13Option Exercise7.283,72327,085243,723Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 13Option Exercise7.286,31345,9277,701Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 13Sale40.016,313252,5831,388Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 13Sale40.033,723149,032240,000Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 12Option Exercise7.2814,413104,855254,413Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 12Option Exercise7.2814,321104,18515,709Jan 13 05:04 PM
HARRISON RICHARD LCFO & TreasurerJan 12Sale40.0014,321572,8401,388Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 12Sale40.0014,413576,520240,000Jan 13 05:04 PM
Calcaterra Chris M.Chief Commercial OfficerJan 09Option Exercise7.2820,000145,500260,000Jan 11 04:30 PM
Calcaterra Chris M.Chief Commercial OfficerJan 09Sale38.0220,000760,400240,000Jan 11 04:30 PM
HARRISON RICHARD LCFO & TreasurerJan 06Option Exercise4.6320,63495,60322,022Jan 09 04:00 PM
HARRISON RICHARD LCFO & TreasurerJan 06Sale35.5820,634734,1421,388Jan 09 04:00 PM
Burns Thomas WilliamChief Executive OfficerDec 14Option Exercise1.258,00010,000299,388Dec 16 04:17 PM
LINK WILLIAM J PHDDirectorNov 17Sale33.7830,0001,013,40087,695Nov 18 04:23 PM
Burns Thomas WilliamChief Executive OfficerNov 15Sale34.0310,000340,300290,000Nov 15 04:59 PM
Burns Thomas WilliamChief Executive OfficerNov 14Option Exercise1.68190,120319,055490,120Nov 15 04:59 PM
Burns Thomas WilliamChief Executive OfficerNov 14Sale33.66190,1206,399,557300,000Nov 15 04:59 PM
Calcaterra Chris M.Chief Commercial OfficerOct 24Option Exercise7.2820,000145,500260,000Oct 25 04:55 PM
Calcaterra Chris M.Chief Commercial OfficerOct 24Sale36.0120,000720,200240,000Oct 25 04:55 PM
Calcaterra Chris M.Chief Commercial OfficerOct 20Option Exercise7.2840,000291,000280,000Oct 20 06:37 PM
Calcaterra Chris M.Chief Commercial OfficerOct 20Sale34.7640,0001,390,570240,000Oct 20 06:37 PM